LRIG1 and cancer: Since IL-17 induces the activation, proliferation, and epithelial-to-mesenchymal transition of quiescent Lrig1 expressing epithelial stem cells [165], and Lrig1 can be induced in cancer cells, IL-17 signaling could provide better survival of tumor cells after chemo- or radio-therapy.